BioPorto
Logotype for BioPorto

BioPorto (BIOPOR) investor relations material

BioPorto Guidance summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for BioPorto
Guidance summary6 Feb, 2026

Opening remarks and agenda

  • Preliminary unaudited 2025 financial figures and 2026 guidance were presented, with a business update on strategic progress and future milestones.

Guidance on key objectives

  • 2026 total NGAL revenue projected at DKK 33–42m, representing 20–50% growth and targeting over 60 active US hospitals.

  • 2026 total revenue expected at DKK 48–58m, a 20–45% increase, with revenue expected to be back-end loaded.

  • Adjusted EBITDA loss for 2026 forecasted at DKK 50–60m, a 22–35% improvement due to higher revenues and cost reductions.

  • Aspirations for 2028 remain unchanged: revenue of DKK 150–200m and adjusted EBITDA margin of at least 15%.

  • Cash flow is expected to turn positive in 2H 2027, with current cash covering projected spending through 2026.

Market trends and strategic opportunities

  • Early detection of AKI remains a major unmet need; ProNephro AKI (NGAL) is the first FDA-cleared pediatric AKI test.

  • Defined pathway for FDA approval and commercial launch for adult indication in the US, with clinical validation study to be initiated in 1H 2026.

  • Addressable ICU market estimated at approximately USD 700m.

  • NGAL RUO sales in the US showed strong growth in 2025, with 25% year-over-year increase and 44 active hospitals by year-end.

  • Strategic focus on children's hospitals and segmentation in the US market demonstrated value and set the stage for further adoption.

Assess NGAL revenue stability ex-strategic distributors.
What are the specific 2027 funding options?
Key milestones for adult NGAL FDA pre-submission.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next BioPorto earnings date

Logotype for BioPorto
Q4 202526 Mar, 2026
BioPorto
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next BioPorto earnings date

Logotype for BioPorto
Q4 202526 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

BioPorto A/S is a global biotech company that specializes in the development and manufacturing of in-vitro diagnostic tests and antibodies for both research and clinical applications. The company's diagnostics products are primarily based on a patented proprietary technology platform called MoAb®. The Company's products are used in research, including preclinical studies and clinical trials, as well as in diagnosis procedures to detect infectious diseases, cancer, autoimmune disorders and other diseases. BioPorto A/S is based in Hellerup, Denmark.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage